57100-18-2 Usage
General Description
Pseudoisocytidine (Ψ) is a modified nucleoside found in tRNA and rRNA, where it helps stabilize the three-dimensional structure of these molecules. It is formed by the isomerization of cytidine in the presence of a specific enzyme, and it plays a crucial role in the decoding process during protein synthesis. Pseudoisocytidine enhances the efficiency and accuracy of tRNA and rRNA function by promoting the correct pairing between codons and anticodons. Additionally, it has been identified as a potential target for the development of novel antibacterial agents, as it is essential for the survival of certain pathogenic bacteria. Overall, pseudoisocytidine is a key component of the genetic code and has important implications for both basic biological processes and potential therapeutic interventions.
Check Digit Verification of cas no
The CAS Registry Mumber 57100-18-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,1,0 and 0 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 57100-18:
(7*5)+(6*7)+(5*1)+(4*0)+(3*0)+(2*1)+(1*8)=92
92 % 10 = 2
So 57100-18-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H13N3O5/c10-9-11-1-3(8(16)12-9)7-6(15)5(14)4(2-13)17-7/h1,4-7,13-15H,2H2,(H3,10,11,12,16)/t4-,5-,6-,7+/m1/s1
57100-18-2Relevant articles and documents
-
Hirota,K. et al.
, p. 1193 - 1197 (1978)
-
2,4-Dichloro-5-(β-D-ribofuranosyl) pyrimidines and substituted derivatives
-
, (2008/06/13)
A C-nucleoside compound, 2,4-dichloro-5-(2,3,5-Tri-O-acetyl-β-D-Ribofuranosyl)pyrimidine, useful as a primary starting material in the synthesis of various C-nucleoside compounds having antitumor, antiviral and/or antibacterial activity. A structural formula is as follows: STR1 The location of the 2,4-dichloro members on the heterocycle, with the active sites of the carbohydrate being blocked, provides an intermediate compound well adapted for a variety of nucleophilic substitutions. Such procedures have yielded several novel analogs of known pyrimidine nucleosides found in RNA, as well as other compounds which have demonstrated chemotherapeutic utility.
